JP2015524432A5 - - Google Patents

Download PDF

Info

Publication number
JP2015524432A5
JP2015524432A5 JP2015524242A JP2015524242A JP2015524432A5 JP 2015524432 A5 JP2015524432 A5 JP 2015524432A5 JP 2015524242 A JP2015524242 A JP 2015524242A JP 2015524242 A JP2015524242 A JP 2015524242A JP 2015524432 A5 JP2015524432 A5 JP 2015524432A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
apolipoprotein
protein
biologically active
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015524242A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015524432A (ja
JP6033433B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/066334 external-priority patent/WO2014018079A1/en
Publication of JP2015524432A publication Critical patent/JP2015524432A/ja
Publication of JP2015524432A5 publication Critical patent/JP2015524432A5/ja
Application granted granted Critical
Publication of JP6033433B2 publication Critical patent/JP6033433B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015524242A 2012-07-25 2012-11-21 アポリポタンパク質ａｉｖを用いて高血糖障害を治療する方法 Expired - Fee Related JP6033433B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261675549P 2012-07-25 2012-07-25
US61/675,549 2012-07-25
PCT/US2012/066334 WO2014018079A1 (en) 2012-07-25 2012-11-21 Method of treating hyperglycemic disorders using apoliprotein aiv

Publications (3)

Publication Number Publication Date
JP2015524432A JP2015524432A (ja) 2015-08-24
JP2015524432A5 true JP2015524432A5 (https=) 2016-01-21
JP6033433B2 JP6033433B2 (ja) 2016-11-30

Family

ID=47295208

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015524242A Expired - Fee Related JP6033433B2 (ja) 2012-07-25 2012-11-21 アポリポタンパク質ａｉｖを用いて高血糖障害を治療する方法

Country Status (5)

Country Link
US (1) US10232019B2 (https=)
JP (1) JP6033433B2 (https=)
AU (1) AU2012385960B2 (https=)
CA (1) CA2878684A1 (https=)
WO (1) WO2014018079A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140071272A (ko) 2011-01-19 2014-06-11 유니버시티 오브 신시내티 항 당뇨병 펩타이드로서의 아포리포프로테인 ａｉｖ
AU2012366182B2 (en) * 2012-01-19 2017-08-17 University Of Cincinnati Method of treating diabetes using non-glycosylated apolipoprotein A-IV
WO2014018763A2 (en) 2012-07-25 2014-01-30 University Of Cincinnati Method of treating type i diabetes using apolipoprotein aiv

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
EP0402226A1 (en) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Transformation vectors for yeast yarrowia
FR2686605B1 (fr) 1992-01-27 1994-03-11 Rhone Poulenc Rorer Sa Nouveaux polypeptides, leur preparation et leur utilisation.
WO1994027629A1 (en) 1993-05-28 1994-12-08 Merck & Co., Inc. Method to control appetite and treat obesity
US7105489B2 (en) * 2002-01-22 2006-09-12 Amylin Pharmaceuticals, Inc. Methods and compositions for treating polycystic ovary syndrome
BR0310100A (pt) 2002-05-17 2007-04-27 Esperion Therapeutics Inc métodos para tratar, prevenir ou reduzir a lesão de reperfusão isquêmica em um tecido ou órgão, e para prevenir ou tratar de uma condição associada com a privação de oxigênio, seguida por suprimento de oxigênio aumentado a um tecido ou órgão em necessidade disto
US20100267052A1 (en) 2006-09-01 2010-10-21 American Type Culture Collection Compositions and methods for diagnosis and treatment of type 2 diabetes
CA2719001A1 (en) 2008-03-21 2009-09-24 Podiceps B.V. Diagnostic of pre-symptomatic metabolic syndrome
CN103833713B (zh) 2008-11-28 2016-02-03 中国医学科学院药物研究所 硝克柳胺化合物晶iii型、其制法和其药物组合物与用途
KR20140071272A (ko) * 2011-01-19 2014-06-11 유니버시티 오브 신시내티 항 당뇨병 펩타이드로서의 아포리포프로테인 ａｉｖ
AU2012366182B2 (en) 2012-01-19 2017-08-17 University Of Cincinnati Method of treating diabetes using non-glycosylated apolipoprotein A-IV
WO2014011908A1 (en) * 2012-07-11 2014-01-16 Esperion Therapeutics, Inc. Apolipoprotein mixtures
WO2014018763A2 (en) 2012-07-25 2014-01-30 University Of Cincinnati Method of treating type i diabetes using apolipoprotein aiv

Similar Documents

Publication Publication Date Title
Cahn et al. New forms of insulin and insulin therapies for the treatment of type 2 diabetes
JP2014526441A5 (https=)
JP5552046B2 (ja) インスリン誘導体を含有する薬学的製剤
JP2010031018A5 (https=)
EP2611458B1 (en) Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
EP2976096B1 (en) Insulin dosing regimen
US7485620B2 (en) Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof
US20080213288A1 (en) Combined Use Of A Modulator Of CD3 And A GLP-1 Compound
RU2013133803A (ru) Способы лечения метаболических нарушений и ожирения при помощи пептидов на основе глюкагона, активных по отношению к рецепторам гип и гпп
JP2020062028A5 (https=)
JP2018504111A (ja) ＧＬＰ及び免疫グロブリンハイブリッドＦｃ融合ポリペプチド及びその用途
JP2016512205A5 (https=)
JP2010514694A5 (https=)
EP3268029B1 (en) Treatment of type 2 diabetes mellitus patients
JP2016514132A (ja) ヒト成長ホルモン類似体を用いた小児成長ホルモン分泌不全症の治療
JP2012509283A5 (https=)
JP2020533302A (ja) 肥満の治療において使用するためのｍｉｃ−１およびｇｌｐ−１
JP2020502150A5 (https=)
JP2020502151A5 (https=)
CN1993137A (zh) 用于治疗心血管疾病的组合物和方法
JP2014504601A5 (https=)
JP2015524432A5 (https=)
JP2022060514A (ja) ガバペンチノイドからの干渉が減少し、ｈｇｆ異型体を発現するｄｎａコンストラクトを用いる神経病症の治療
JP2014129405A5 (https=)
Manolis et al. Cardiovascular safety of antihyperglycemic agents:“do good or do no harm”